anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

234,781-234,810 of 319,975

filter-aware
23
The slide uses a table to establish historical and modern clinical validity for LSD therapy.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · Product1 hit
24
The chart highlights statistical significance at specific time points (Week 1, 2, 4, 8, 12) using asterisks.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · Product1 hit
25
The slide outlines the study structure for MM120-310, with MM120-311 design pending.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · Product1 hit
26
Includes study design, randomization, primary endpoint, entry criteria, and secondary endpoints.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · Product1 hit
27
MindMed | Investor Presentation Deck | 42 slidesMindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · Product1 hit
28
The slide emphasizes regulatory alignment and standard clinical trial methodology.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations Beat · Product1 hit
29
Includes study design, dosing arms, primary/secondary endpoints, and entry criteria.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations 1 hit
30
The slide uses a table to contrast what is included in the patient journey versus what is explicitly excluded (no preparation, no assisted therapy, no integration).MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations 1 hit
31
The slide uses a process flow diagram to track patient retention from randomization through 12 weeks.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations 1 hit
32
The table shows n=194 total participants across 5 cohorts. HAM-A and CGI-S are standard clinical scales for anxiety and severity of illness.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations 1 hit
33
The chart highlights the 100ug dose group performance relative to placebo and other doses.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations 1 hit
34
Data shows a clear dose-response relationship peaking at 100ug.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations 1 hit
35
MCP-Mod is a statistical methodology for dose-response modeling.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations 1 hit
36
The chart demonstrates efficacy of a drug candidate in a clinical trial setting.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations 1 hit
37
The slide uses a structured list format to present clinical safety findings.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations 1 hit
38
The table shows high incidence of specific events like Illusion and Nausea on Dosing Day, but very low incidence After Dosing Day, supporting the 'favorable tolerability' claim.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations 1 hit
39
MindMed | Investor Presentation Deck | 42 slidesMindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations 1 hit
40
The slide uses a biological process diagram to explain the drug's effect on neurotransmitters and subsequent clinical outcomes.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations 1 hit
41
The slide uses a bar chart to demonstrate efficacy in an animal model and an icon grid to summarize clinical benefits.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations 1 hit
42
This appears to be a closing or transition slide, though it functions as a cover-style branding slide.MindMed | Investor Presentation Deck | 42 slides · MindMed
Pitch deck Investor relations 1 hit
01
Slide 1
ModivCare | Investor Presentation Deck | 36 slidesModivCare | Investor Presentation Deck | 36 slides · ModivCare
Pitch deck Investor relations 1 hit
02
ModivCare | Investor Presentation Deck | 36 slidesModivCare | Investor Presentation Deck | 36 slides · ModivCare
Pitch deck Investor relations 1 hit
03
The slide uses a grid-based layout to categorize three main business lines: Transportation, Personal Care, and Remote Monitoring.ModivCare | Investor Presentation Deck | 36 slides · ModivCare
Pitch deck Investor relations Beat · Market Size1 hit
04
The slide uses a matrix-like layout to compare three distinct business units.ModivCare | Investor Presentation Deck | 36 slides · ModivCare
Pitch deck Investor relations Beat · Market Size1 hit
05
ModivCare | Investor Presentation Deck | 36 slidesModivCare | Investor Presentation Deck | 36 slides · ModivCare
Pitch deck Investor relations 1 hit
06
Includes segment-level breakdown for NEMT, Personal Care, RPM, and Corporate.ModivCare | Investor Presentation Deck | 36 slides · ModivCare
Pitch deck Investor relations Beat · Financials1 hit
07
The chart illustrates the bridge between beginning and ending cash balances for the third quarter of 2024.ModivCare | Investor Presentation Deck | 36 slides · ModivCare
Pitch deck Investor relations Beat · Financials1 hit
08
The chart uses a standard waterfall bridge format to explain EBITDA variance.ModivCare | Investor Presentation Deck | 36 slides · ModivCare
Pitch deck Investor relations Beat · Financials1 hit
09
Includes footnotes regarding EBITDA calculation and free cash flow definition.ModivCare | Investor Presentation Deck | 36 slides · ModivCare
Pitch deck Investor relations Beat · Financials1 hit
10
ModivCare | Investor Presentation Deck | 36 slidesModivCare | Investor Presentation Deck | 36 slides · ModivCare
Pitch deck Investor relations 1 hit